EP 1131428 A2 20010912 - IMMUNOGLOBULIN SUPERFAMILY PROTEINS
Title (en)
IMMUNOGLOBULIN SUPERFAMILY PROTEINS
Title (de)
PROTEINE DER IMMUNOGLOBULIN-SUPERFAMILIE
Title (fr)
PROTEINES DE LA SUPERFAMILLE DES IMMUNOGLOBULINES
Publication
Application
Priority
- US 9927566 W 19991119
- US 19585398 A 19981119
- US 11363598 P 19981222
- US 12819499 P 19990407
Abstract (en)
[origin: WO0029583A2] The invention provides human immunoglobulin superfamily proteins (IGFAM) and polynucleotides which identify and encode IGFAM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of IGFAM.
IPC 1-7
C12N 15/12; C12N 5/10; C07K 14/705; C07K 16/28; C12Q 1/68; G01N 33/50; A61K 38/17
IPC 8 full level
G01N 33/53 (2006.01); A61K 38/00 (2006.01); A61K 39/395 (2006.01); A61P 1/04 (2006.01); A61P 1/16 (2006.01); A61P 1/18 (2006.01); A61P 3/10 (2006.01); A61P 5/14 (2006.01); A61P 7/00 (2006.01); A61P 7/06 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 13/12 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 17/12 (2006.01); A61P 19/02 (2006.01); A61P 19/06 (2006.01); A61P 19/10 (2006.01); A61P 21/04 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 31/00 (2006.01); A61P 31/04 (2006.01); A61P 31/10 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); A61P 37/00 (2006.01); A61P 37/02 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07K 14/705 (2006.01); C07K 16/18 (2006.01); C07K 16/42 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/02 (2006.01); C12N 15/12 (2006.01); C12P 21/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/566 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 1/16 (2017.12); A61P 1/18 (2017.12); A61P 3/10 (2017.12); A61P 5/14 (2017.12); A61P 7/00 (2017.12); A61P 7/06 (2017.12); A61P 9/00 (2017.12); A61P 9/10 (2017.12); A61P 11/00 (2017.12); A61P 11/06 (2017.12); A61P 13/12 (2017.12); A61P 17/00 (2017.12); A61P 17/06 (2017.12); A61P 17/12 (2017.12); A61P 19/02 (2017.12); A61P 19/06 (2017.12); A61P 19/10 (2017.12); A61P 21/04 (2017.12); A61P 25/28 (2017.12); A61P 29/00 (2017.12); A61P 31/00 (2017.12); A61P 31/04 (2017.12); A61P 31/10 (2017.12); A61P 31/12 (2017.12); A61P 31/18 (2017.12); A61P 35/00 (2017.12); A61P 35/02 (2017.12); A61P 37/00 (2017.12); A61P 37/02 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); C07K 14/70503 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 0029583A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0029583 A2 20000525; WO 0029583 A3 20000908; AU 1631000 A 20000605; EP 1131428 A2 20010912; JP 2002530080 A 20020917
DOCDB simple family (application)
US 9927566 W 19991119; AU 1631000 A 19991119; EP 99959059 A 19991119; JP 2000582566 A 19991119